Pinnacle Associates’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-902,921
| Closed | -$17M | – | 740 |
|
|
2019
Q3 | $17M | Buy |
902,921
+52,120
| +6% | +$983K | 0.4% | 68 |
|
|
2019
Q2 | $10M | Sell |
850,801
-70,303
| -8% | -$827K | 0.23% | 120 |
|
|
2019
Q1 | $12.6M | Sell |
921,104
-5,963
| -0.6% | -$81.4K | 0.28% | 97 |
|
|
2018
Q4 | $9.5M | Sell |
927,067
-55,162
| -6% | -$565K | 0.25% | 115 |
|
|
2018
Q3 | $16.4M | Sell |
982,229
-142,956
| -13% | -$2.38M | 0.34% | 82 |
|
|
2018
Q2 | $17.8M | Sell |
1,125,185
-175,625
| -14% | -$2.77M | 0.37% | 79 |
|
|
2018
Q1 | $16.5M | Sell |
1,300,810
-47,820
| -4% | -$607K | 0.32% | 86 |
|
|
2017
Q4 | $15.4M | Buy |
1,348,630
+138,550
| +11% | +$1.59M | 0.3% | 89 |
|
|
2017
Q3 | $14.8M | Buy |
+1,210,080
| New | +$14.8M | 0.27% | 97 |
|